Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly Bortezomib in Newly Diagnosed Multiple Myeloma
NCT01090921Phase 2Completed
- Sponsor
- Boston VA Research Institute
- Start
- May 2007
- Primary completion
- Mar 2015
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in multiple myeloma (MM), sponsored by Boston VA Research Institute. Started May 2007; status: completed.
02
Drugs
bortezomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01090921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01090921.